This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Search results
From Proteopedia
You searched for Immunotherapeutic
There is no page with the exact title "Immunotherapeutic". The search results for "Immunotherapeutic" are displayed below. You can create a page titled Immunotherapeutic (by clicking on the red link).
For more information about searching Proteopedia, see Help.
Showing below up to 20 results starting with #1.
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
Article title matches
- Category:Immunotherapeutic agent (54 bytes)
1: List of pages with the keyword Immunotherapeutic agent - Category:Immunotherapeutic (48 bytes)
1: List of pages with the keyword Immunotherapeutic
Page text matches
- 3w2d (4,196 bytes)
14: ...lizing antibodies have been shown to be effective immunotherapeutic agents against this toxin, but the structural bas... - 2wa0 (4,417 bytes)
23: ...active target for the development of targeted and immunotherapeutic cancer treatments. Some MAGE proteins are thought... - 2vwd (5,114 bytes)
24: ... for these viruses has enabled the development of immunotherapeutic reagents which prevent virus attachment and subse... - 2qhr (4,234 bytes)
23: ...or humanization and development of a postexposure immunotherapeutic. - Category:Immunotherapeutic agent (54 bytes)
1: List of pages with the keyword Immunotherapeutic agent - 2jrv (3,744 bytes)
13: Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis.,Jung H... - 2jrw (3,748 bytes)
13: Structural analysis of immunotherapeutic peptides for autoimmune Myasthenia gravis.,Jung H... - 3c3v (3,878 bytes)
21: ...city of food allergens and for the development of immunotherapeutic agents. Previously, we have reported the crystall... - 3csy (13,107 bytes)
25: ...chanism of EBOV GP-mediated fusion and for future immunotherapeutic development. - 3ft2 (14,035 bytes)
26: ... the choice of tumor peptides for stem cell-based immunotherapeutic application. - 3ft3 (5,847 bytes)
25: ... the choice of tumor peptides for stem cell-based immunotherapeutic application. - 3ft4 (5,829 bytes)
25: ... the choice of tumor peptides for stem cell-based immunotherapeutic application. - 3ifl (10,472 bytes)
25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ... - 3ifn (10,473 bytes)
25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ... - 3ifo (10,471 bytes)
25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ... - 3ifp (10,472 bytes)
25: ...dy. These findings provide a structural basis for immunotherapeutic strategies targeting Abeta species postulated to ... - 3rtq (5,012 bytes)
14: ...NKT) cells by CD1d-presented agonists is a potent immunotherapeutic tool. alpha-Galactosylceramide (alpha-GalCer) is ... - 3smh (3,276 bytes)
12: ...rgens should be employed in future diagnostic and immunotherapeutic strategies. - 3u0t (9,169 bytes)
31: [[Category: Immunotherapeutic]] - 4kjy (3,937 bytes)
15: Engineered SIRPalpha variants as immunotherapeutic adjuvants to anticancer antibodies.,Weiskopf K, R...
View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)
You may also try
